Is this you? Create Your Porfile
Avatar

Michael D. Kaufman

Eli Lilly and Company

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Michael D. Kaufman is active.

Explore More

Publication

Featured researches published by Michael D. Kaufman.

Archive | 2007

Kinase inhibitors useful for the treatment of proliferative diseases

Daniel L. Flynn; Peter A. Petillo; Michael D. Kaufman; William C. Patt

Archive | 2011

Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases

Daniel L. Flynn; Peter A. Petillo; Michael D. Kaufman

Archive | 2009

Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities

Daniel L. Flynn; Peter A. Petillo; Michael D. Kaufman

Archive | 2011

Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities

Daniel L. Flynn; Michael D. Kaufman

Archive | 2013

2-AMINO, 6-PHENYL SUBSTITUTED PYRIDO [2, 3 - D] PYRIMIDINE DERIVATIVES USEFUL AS RAF KINASE INHIBITORS

Matthew Carl Allgeier; Daniel L. Flynn; Michael D. Kaufman; Phenil J. Patel; Craig Daniel Wolfangel

Archive | 2013

RAF INHIBITOR COMPOUNDS

Matthew Carl Allgeier; Daniel L. Flynn; Michael D. Kaufman; Phenil J. Patel; Craig Daniel Wolfangel

Archive | 2009

N-acyl ureas exhibiting anti-cancer and anti-proliferative activities

Daniel L. Flynn; Peter A. Petillo; Michael D. Kaufman

Archive | 2007

Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

Daniel L. Flynn; Peter A. Petillo; Michael D. Kaufman; William C. Patt

Archive | 2015

INHIBITION OF TUMOR CELL INTERACTIONS WITH THE MICROENVIRONMENT RESULTING IN A REDUCTION IN TUMOR GROWTH AND DISEASE PROGRESSION

Daniel L. Flynn; Michael D. Kaufman; Bryan D. Smith

Archive | 2014

METHODS FOR INHIBITING TIE-2 KINASE USEFUL IN THE TREATMENT OF CANCER

Daniel L. Flynn; Michael D. Kaufman; Bryan D. Smith; Marc S. Rudoltz

Explore More

Collaboration

Dive into the Michael D. Kaufman's collaboration.

Top Co-Authors
Avatar

Peter A. Petillo

Oregon Health

View shared research outputs
Top Co-Authors
Avatar

Timothy M. Caldwell

University of Kansas

View shared research outputs
Top Co-Authors
Avatar

Craig Daniel Wolfangel

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Lakshminarayana Vogeti

Southern Methodist University

View shared research outputs
Top Co-Authors
Avatar

Matthew Carl Allgeier

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Phenil J. Patel

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Thiwanka Bandara Samarakoon

University of Kansas

View shared research outputs
Top Co-Authors
Avatar

Bryan D. Smith

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors
Avatar

Daniel L. Flynn

G. D. Searle

View shared research outputs
Top Co-Authors
Avatar

Hanumaiah Telikepalli

University of Kansas

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge